What Is Hemochromatosis? Iron Overload and Your Liver

Hemochromatosis is a genetic condition in which your body absorbs too much iron from your diet — and the excess iron deposits in your organs, particularly your liver, causing progressive damage. It's one of the most common inherited disorders in people of Northern European descent (affecting approximately 1 in 200–300 people), yet it remains dramatically underdiagnosed because its symptoms are vague, develop slowly, and are easily attributed to other causes.

The irony of hemochromatosis: the treatment is medieval in its simplicity — removing blood (phlebotomy) — and remarkably effective when started before significant organ damage occurs. The tragedy is that many patients aren't diagnosed until they've already developed cirrhosis, diabetes, or heart disease from decades of iron accumulation that could have been prevented with a simple blood test.

How iron overload damages your liver

Iron is essential — it's a component of hemoglobin (carries oxygen in blood) and hundreds of enzymes. But excess iron is toxic. Your body has no mechanism for actively excreting iron — you lose only small amounts through shed skin cells, GI tract lining, and menstruation. Iron balance depends entirely on controlling absorption.

In hemochromatosis, the control mechanism is broken. The gene mutation (most commonly C282Y in the HFE gene) disrupts hepcidin — the hormone that regulates iron absorption from the gut. Without adequate hepcidin signaling, the intestines absorb 2–4 times more iron than normal from every meal. Over years, this excess accumulates — and the liver, as the primary iron storage organ, bears the brunt.

Excess iron in liver cells generates reactive oxygen species (free radicals) through the Fenton reaction — a chemical process where iron catalyzes the production of highly destructive hydroxyl radicals. These free radicals damage cell membranes, proteins, and DNA — causing chronic inflammation, hepatocyte death, stellate cell activation (fibrosis production), and eventually cirrhosis.

The progression is gradual: iron accumulation begins at birth but clinical disease rarely appears before age 40 in men or after menopause in women (because menstruation provides a natural iron-removal mechanism that delays overload). By the time symptoms develop, the liver may already be significantly damaged.

Symptoms: the "bronze diabetes" and beyond

Hemochromatosis was historically called "bronze diabetes" — a name describing two of its classic late-stage features: skin darkening (from iron deposition in the skin) and diabetes (from iron damaging the pancreas). But these are late findings. The earlier symptoms are maddeningly nonspecific:

• Fatigue and weakness — the most common complaint, present in 75% of symptomatic patients. Easily attributed to overwork, aging, or stress.

• Joint pain — particularly the first two finger joints (second and third metacarpophalangeal joints). This specific pattern is highly suggestive of hemochromatosis but is often misdiagnosed as osteoarthritis or rheumatoid arthritis.

• Abdominal pain — right upper quadrant discomfort from liver enlargement.

• Loss of libido and erectile dysfunction — from iron depositing in the pituitary gland and disrupting sex hormone production (hypogonadotropic hypogonadism).

• Heart palpitations or arrhythmias — from iron depositing in the heart (cardiomyopathy).

• Skin darkening — a bronze or gray-brown discoloration, particularly on sun-exposed areas.

• Diabetes — from iron damaging pancreatic beta cells. "Bronze diabetes" is a late, advanced finding.

• Liver disease — elevated liver enzymes, hepatomegaly, fibrosis, cirrhosis, and HCC.

The tragedy: by the time the classic triad of skin darkening, diabetes, and liver disease appears, the disease has been active for 20–30+ years of accumulated iron damage. The diagnostic window is decades earlier — when only fatigue, joint pain, and mildly elevated ferritin hint at what's happening.

Diagnosis: the tests that find it

Initial screening

Serum ferritin and transferrin saturation (TSAT) are the initial screening tests.

Important caveat: Ferritin is an acute phase reactant — it rises with inflammation, infection, alcohol use, fatty liver, and liver disease from any cause. A high ferritin doesn't automatically mean hemochromatosis. Transferrin saturation is more specific — TSAT >45% in a fasting sample is the most reliable initial indicator.

Genetic testing

If iron studies suggest overload, HFE gene testing confirms hereditary hemochromatosis. The C282Y homozygous mutation (inheriting the C282Y variant from both parents) is the most common cause — found in approximately 85–90% of clinically significant hemochromatosis cases in people of Northern European descent. C282Y/H63D compound heterozygosity and H63D homozygosity cause milder phenotypes that rarely cause clinically significant iron overload.

Liver assessment

FibroScan (liver stiffness measurement) assesses fibrosis stage. MRI with T2* quantification can measure liver iron concentration non-invasively — replacing the need for liver biopsy in most cases. Liver biopsy is now reserved for cases where fibrosis staging is uncertain or when ferritin is very high (>1,000 ng/mL) and fibrosis is suspected. Use the Liver Enzyme Checker to evaluate your liver panel.

Treatment: phlebotomy — the medieval cure that works

The primary treatment for hemochromatosis is beautifully simple: remove blood. Each unit of blood (approximately 500 mL) removes roughly 200–250 mg of iron. Your body then mobilizes iron from storage (including the liver) to make new red blood cells — gradually depleting the excess.

Induction phase

Weekly or biweekly phlebotomy until ferritin drops below 50–100 ng/mL. This can take 6 months to 2+ years depending on how much iron has accumulated. Each session takes about 30–45 minutes (similar to donating blood). You'll feel somewhat tired afterward — hydrate well and avoid strenuous activity for the rest of the day.

Maintenance phase

Once ferritin is in the target range, phlebotomy frequency drops to every 2–4 months — enough to keep iron from reaccumulating. Ferritin is monitored regularly (every 3–6 months) and phlebotomy frequency is adjusted to maintain levels below 50–100 ng/mL. This is lifelong — because your body will continue absorbing excess iron from your diet.

What if phlebotomy isn't possible?

Some patients can't tolerate phlebotomy (severe anemia, heart failure, poor venous access). Iron chelation therapy (deferasirox — an oral medication that binds iron and facilitates its excretion) is an alternative, though it's less commonly used than phlebotomy for hereditary hemochromatosis.

Does treatment reverse liver damage?

If caught before cirrhosis develops — yes. Iron depletion through phlebotomy reduces liver inflammation, can reverse fibrosis, normalizes liver enzymes, and dramatically improves long-term survival. Patients diagnosed and treated before cirrhosis have essentially normal life expectancy.

If cirrhosis has already developed — phlebotomy still helps (reduces inflammation, slows progression, and may partially improve fibrosis), but the structural cirrhosis doesn't fully reverse. Patients with hemochromatosis-related cirrhosis need standard cirrhosis care: HCC screening every 6 months (hemochromatosis-cirrhosis has one of the highest HCC rates among all cirrhosis causes), variceal screening, ascites management, and transplant evaluation when indicated.

Key message: The earlier hemochromatosis is detected, the more completely the damage is reversible. This is one of the strongest arguments for screening — a simple ferritin + transferrin saturation can change the trajectory of a lifetime of iron accumulation.

Who should be screened

• First-degree relatives (siblings, children, parents) of anyone diagnosed with hemochromatosis — testing should include both iron studies AND HFE gene testing.

• Anyone with persistently elevated ferritin — after excluding common causes (inflammation, alcohol, metabolic syndrome).

• Anyone with transferrin saturation >45% on a fasting blood test.

• Patients with unexplained liver disease — elevated enzymes, fibrosis, or cirrhosis without a clear cause.

• Men with unexplained fatigue + joint pain + elevated liver enzymes — this combination should trigger iron studies.

• Northern European descent with any of the above — the C282Y mutation is most prevalent in Irish, Scottish, Scandinavian, and Northern European populations.

Dietary considerations

Dietary iron restriction alone is NOT sufficient to manage hemochromatosis — phlebotomy is the primary treatment. However, dietary awareness helps:

• Avoid iron supplements — including multivitamins that contain iron. Check every supplement label.

• Limit red meat — the highest dietary source of heme iron (the most easily absorbed form).

• Avoid vitamin C supplements with meals — vitamin C dramatically increases iron absorption from food. Whole fruit with meals is fine; megadose vitamin C supplements are not.

• Avoid raw shellfish — hemochromatosis patients are susceptible to Vibrio vulnificus infection (a potentially fatal bacterium found in raw oysters and shellfish). Always cook shellfish thoroughly.

• Tea and coffee with meals — tannins in tea and polyphenols in coffee inhibit iron absorption. Drinking tea or coffee with meals modestly reduces dietary iron uptake.

• Zero alcohol — alcohol and iron overload synergistically damage the liver. Even moderate drinking in hemochromatosis dramatically increases cirrhosis risk.

Tracking your iron and liver health

Upload every lab report to LiverTracker. Your ferritin, transferrin saturation, liver enzymes, and all other values are tracked on visual trend charts. Watching ferritin decline over your phlebotomy sessions — from 1,500 → 800 → 400 → 200 → 80 — is both clinically meaningful and psychologically motivating. The trend chart shows the treatment working in real time.

Log your phlebotomy dates and ferritin levels. Log your FibroScan and imaging results. Share your complete record with your hepatologist or hematologist at every visit.

Frequently asked questions

Is hemochromatosis common?

The C282Y homozygous genotype is present in approximately 1 in 200–300 people of Northern European descent — making it one of the most common genetic disorders in this population. However, not all carriers develop clinical disease (penetrance varies). Approximately 28–50% of C282Y homozygous men and 1–2% of homozygous women eventually develop clinically significant iron overload. Even so, many are never diagnosed.

Can women get hemochromatosis?

Yes — but they typically present later than men (after menopause) because menstruation provides natural iron removal during reproductive years. Once menstruation stops, iron accumulates without this safety valve, and women can develop the same organ damage as men. Women with hemochromatosis who have early menopause or very light periods may present earlier.

Should my children be tested?

If you have hemochromatosis (confirmed C282Y homozygosity), your children have at least one C282Y gene. Whether they have two (and are at risk for clinical disease) depends on your partner's carrier status. Your partner should be tested for C282Y/H63D mutations. If your partner also carries one copy, each child has a 25% chance of being homozygous. Genetic counseling can guide family screening.

Can I donate my phlebotomy blood?

In many countries and blood banks — yes. Hemochromatosis blood is safe for transfusion recipients (the excess iron is in your body's stores, not in the red blood cells themselves). Blood donation through your local blood bank satisfies both your treatment need and a community need. However, policies vary — check with your blood bank. In some jurisdictions, therapeutic phlebotomy blood must be labeled differently.

Will phlebotomy cure my joint pain?

Unfortunately, joint damage from iron deposition is one of the least reversible manifestations of hemochromatosis. Arthropathy often persists or even worsens after iron depletion — possibly because iron triggers calcium pyrophosphate crystal deposition (pseudogout) in joints that continues even after iron levels normalize. Joint management may require anti-inflammatory approaches alongside iron depletion.

Too much iron is as dangerous as too little — and your liver pays the price first. A simple blood test finds it. A simple treatment fixes it. But only if someone thinks to check.

→ Check Your Liver Enzymes Free

→ Start Tracking Free

→ Take the Liver Health Quiz

Medical Disclaimer: This article is for informational and educational purposes only. Hemochromatosis management should be directed by a hepatologist or hematologist. Never take iron supplements if you have or are at risk for hemochromatosis. Visit livertracker.com/medical-disclaimer.